Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,684.08 +380.47 (+0.60%) CMC Crypto 200
1,393.93 -2.61 (-0.19%)
Verona Pharma plc (VRNA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.20B |
| Enterprise value | 977.65M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 4.81 |
| Enterprise value/revenue | 2.53k |
| Enterprise value/EBITDA | -19.11 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.41 |
| 52-week change 3 | -25.34% |
| S&P500 52-week change 3 | 22.36% |
| 52-week high 3 | 23.81 |
| 52-week low 3 | 11.83 |
| 50-day moving average 3 | 16.35 |
| 200-day moving average 3 | 16.88 |
Share statistics
| Avg vol (3-month) 3 | 440.36k |
| Avg vol (10-day) 3 | 424.27k |
| Shares outstanding 5 | 77.45M |
| Implied shares outstanding 6 | 48.09M |
| Float 8 | 477.98M |
| % held by insiders 1 | 4.28% |
| % held by institutions 1 | 85.04% |
| Shares short (15 Apr 2024) 4 | 6.07M |
| Short ratio (15 Apr 2024) 4 | 15.94 |
| Short % of float (15 Apr 2024) 4 | 8.20% |
| Short % of shares outstanding (15 Apr 2024) 4 | 7.83% |
| Shares short (prior month 15 Mar 2024) 4 | 6.4M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -14.64% |
| Return on equity (ttm) | -22.67% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -65.79M |
| Net income avi to common (ttm) | -54.37M |
| Diluted EPS (ttm) | -0.72 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 271.77M |
| Total cash per share (mrq) | 0.42 |
| Total debt (mrq) | 51.33M |
| Total debt/equity (mrq) | 20.59% |
| Current ratio (mrq) | 33.33 |
| Book value per share (mrq) | 3.10 |
Cash flow statement
| Operating cash flow (ttm) | -50.22M |
| Levered free cash flow (ttm) | -36.63M |
© 2024 Yahoo. All rights reserved.